Alliances Expand the Reach and Impact of Our Technology
Valued partnerships are essential to our business model. Solixia's research collaborations with academic medical centers have provided us with key insights into the future of tumor-targeted radioactivity for cancer diagnosis and treatment.
We are seeking co-development or licensing relationships with companies that own disease-associated targets, immunology scaffolds, and/or proprietary targeting systems including monoclonal antibodies.
To learn more, please contact our business development team at bd@solixia.com